DE602006018471D1 - 17-alpha-substituierte derivate von östradiol mit wundheilender wirkung - Google Patents
17-alpha-substituierte derivate von östradiol mit wundheilender wirkungInfo
- Publication number
- DE602006018471D1 DE602006018471D1 DE602006018471T DE602006018471T DE602006018471D1 DE 602006018471 D1 DE602006018471 D1 DE 602006018471D1 DE 602006018471 T DE602006018471 T DE 602006018471T DE 602006018471 T DE602006018471 T DE 602006018471T DE 602006018471 D1 DE602006018471 D1 DE 602006018471D1
- Authority
- DE
- Germany
- Prior art keywords
- ostradiol
- alpha
- wound healing
- substituted derivatives
- healing effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001516A ITMI20051516A1 (it) | 2005-08-02 | 2005-08-02 | Derivati 17 alfa-sostituti dell'estradiolo ad attivita' cicatrizzante |
| PCT/EP2006/007488 WO2007014711A1 (en) | 2005-08-02 | 2006-07-28 | 17-alpha-substituted derivatives of estradiol with wound-healing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006018471D1 true DE602006018471D1 (de) | 2011-01-05 |
Family
ID=37564355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006018471T Active DE602006018471D1 (de) | 2005-08-02 | 2006-07-28 | 17-alpha-substituierte derivate von östradiol mit wundheilender wirkung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8357675B2 (de) |
| EP (1) | EP1910398B1 (de) |
| AT (1) | ATE489398T1 (de) |
| DE (1) | DE602006018471D1 (de) |
| DK (1) | DK1910398T3 (de) |
| ES (1) | ES2356668T3 (de) |
| IT (1) | ITMI20051516A1 (de) |
| PL (1) | PL1910398T3 (de) |
| PT (1) | PT1910398E (de) |
| WO (1) | WO2007014711A1 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE279916T1 (de) * | 1996-07-22 | 2004-11-15 | Renovo Ltd | Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden |
-
2005
- 2005-08-02 IT IT001516A patent/ITMI20051516A1/it unknown
-
2006
- 2006-07-28 WO PCT/EP2006/007488 patent/WO2007014711A1/en active Application Filing
- 2006-07-28 AT AT06762874T patent/ATE489398T1/de active
- 2006-07-28 EP EP06762874A patent/EP1910398B1/de active Active
- 2006-07-28 PT PT06762874T patent/PT1910398E/pt unknown
- 2006-07-28 PL PL06762874T patent/PL1910398T3/pl unknown
- 2006-07-28 DK DK06762874.3T patent/DK1910398T3/da active
- 2006-07-28 ES ES06762874T patent/ES2356668T3/es active Active
- 2006-07-28 DE DE602006018471T patent/DE602006018471D1/de active Active
- 2006-07-28 US US11/989,807 patent/US8357675B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8357675B2 (en) | 2013-01-22 |
| EP1910398A1 (de) | 2008-04-16 |
| ITMI20051516A1 (it) | 2007-02-03 |
| ATE489398T1 (de) | 2010-12-15 |
| PL1910398T3 (pl) | 2011-05-31 |
| WO2007014711A1 (en) | 2007-02-08 |
| EP1910398B1 (de) | 2010-11-24 |
| US20100035796A1 (en) | 2010-02-11 |
| ES2356668T3 (es) | 2011-04-12 |
| DK1910398T3 (da) | 2011-02-14 |
| PT1910398E (pt) | 2011-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26843A1 (fr) | NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE | |
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
| CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
| CR10838A (es) | Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| HUP0302881A2 (hu) | Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények | |
| CY1105065T1 (el) | Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση | |
| DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| NO20062945L (no) | Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| NO20070372L (no) | Amidoforbindelser og anvendelse derav som farmasoytiske preparater | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
| CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
| EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
| DE50312034D1 (de) | Liposomale glucocorticoide | |
| NO20091191L (no) | Fremgangsmater for behandling av kreft, innbefattende administrering av et vitamin D preparat og et ytterligere terapeutisk middel, og sammensetninger som inneholder de samme | |
| SE0400346D0 (sv) | Steroids for cancer treatment | |
| BRPI0411702B8 (pt) | uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral | |
| NO20083759L (no) | Doserings aerosoler for administrering av farmasoytiske preparater | |
| ME01069B (de) | Transdermales therapeutisches System von Gestoden | |
| SE0300457D0 (sv) | Novel compounds | |
| DE602006018471D1 (de) | 17-alpha-substituierte derivate von östradiol mit wundheilender wirkung | |
| PE20070555A1 (es) | Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral |